LUXE dropped 11.8% on Tuesday after reporting Q3 results that missed on both lines — and the bears barely moved.
Q3 earnings per share came in at a loss of $0.29, against an estimate of $0.18. Revenue of $724.2M fell short of the $734.2M consensus. The stock closed at $6.87 on May 19, down 15.6% on the week and 22.7% over the past month. That is a significant drawdown — and it landed squarely on top of what was already one of the more heavily shorted small-cap retail names in the market.
Short interest has been one of the defining features of LUXE for months. Shorts hold 21.3% of free float, a level that has barely budged through the selloff — it ticked up a fraction on the day of the miss, from 21.17% to 21.28%. The absence of covering is notable. With a 22.6-day days-to-cover reading from the most recent FINRA data, this is not a position that unwinds quickly. Bears are not running for the exits; they are watching the price decline validate their thesis. Borrow conditions are not placing any pressure on them to act. Cost to borrow is a negligible 0.38% annualised. Availability is wide open at 278% — nearly three shares available to borrow for every one already shorted — meaning fresh short supply is plentiful if sentiment sours further.
Options positioning tells a parallel story of caution. The put/call ratio is running at 1.40, nearly 1.8 standard deviations above its 20-day average of 1.23. That is not yet at the elevated levels seen in mid-April — the PCR reached as high as 2.11 earlier this spring — but it has climbed sharply since early May, when it was sitting closer to 1.10. Buyers of downside protection have been accumulating quietly ahead of, and now through, the earnings print.
The Street's reaction was swift. TD Cowen maintained its Buy rating on May 20 but cut its price target to $8 from a higher level — a downgrade in conviction if not in rating. A separate research aggregator flagged LUXE among the most actively downgraded names on May 18, the day before results. That the stock is trading at $6.87 with a $8 Buy target from one of its remaining bulls illustrates how compressed the bull case has become. On fundamentals, the EV/EBITDA multiple has fallen sharply — down roughly 16.8x over the past 30 days to 26.7x — tracking the price lower. The company itself offered a note of reassurance: management confirmed full fiscal year 2026 guidance and cited positive adjusted EBITDA for the second consecutive quarter as evidence that the transformation plan remains on track. The ORTEX short score is elevated at 78.4, near its highest reading of the past several weeks, reflecting the combination of heavy positioning and price weakness.
Ownership is tightly held. Myt Holding LLC controls 48.4% of shares and Compagnie Financière Richemont holds a further 36.2%. Together those two anchor shareholders account for over 84% of the register. The tradeable float is thin by design, which amplifies any move in either direction. Among active managers, Portolan Capital added over one million shares in Q1 2026, and Stoic Point Capital built a new position of 1.6M shares — two funds buying into a name that the short side is also actively pressing. That divergence between long-only accumulation and persistent short positioning is the core tension in LUXE's shareholder base.
The next event to watch is whether management's guidance confirmation holds through subsequent quarterly data points, and whether the stock's proximity to its lows draws fresh institutional demand or accelerates further covering decisions from the long side.
See the live data behind this article on ORTEX.
Open LUXE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
